Literature DB >> 15102749

In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi.

Guillermo Garcia-Effron1, Alicia Gomez-Lopez, Emilia Mellado, Araceli Monzon, Juan L Rodriguez-Tudela, Manuel Cuenca-Estrella.   

Abstract

OBJECTIVES: The activity in vitro of terbinafine against 442 clinical isolates of several species of filamentous fungi was analysed.
METHODS: A broth microdilution test was carried out following the National Committee for Clinical Laboratory Standards reference method, with modifications described previously.
RESULTS: The geometric mean (GM) of MICs of terbinafine for non-Aspergillus fumigatus species was 0.24 mg/L whereas the GM for A. fumigatus rose as far as 2.92 mg/L. Terbinafine showed a very strong activity in vitro against Penicillium spp., Paecilomyces spp., Trichoderma spp., Acremonium spp. and Arthrographis spp. with GMs <1 mg/L. However, some species such as Scedosporium spp., Fusarium spp., Scopulariopsis brevicaulis, and most of Mucorales exhibited high MICs of the allylamine with GMs >/= 4 mg/L.
CONCLUSIONS: Overall, the GM of MICs of terbinafine was 1.57 mg/L, but significant differences in susceptibilities were seen between genera and species.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15102749     DOI: 10.1093/jac/dkh228

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  14 in total

1.  In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Maria J Buitrago; Emilia Mellado; Guillermo Garcia-Effron; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  Treatment options in emerging mold infections.

Authors:  Patricia Muñoz; Jesús Guinea; Emilio Bouza
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

3.  In vitro activities of amphotericin B, terbinafine, and azole drugs against clinical and environmental isolates of Aspergillus terreus sensu stricto.

Authors:  Mariana S Fernández; Florencia D Rojas; María E Cattana; María de Los Ángeles Sosa; Cristina A Iovannitti; Cornelia Lass-Flörl; Gustavo E Giusiano
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

4.  Use of Antifungal Combination Therapy: Agents, Order, and Timing.

Authors:  Melissa D Johnson; John R Perfect
Journal:  Curr Fungal Infect Rep       Date:  2010-05-01

5.  Phylogeny of the clinically relevant species of the emerging fungus Trichoderma and their antifungal susceptibilities.

Authors:  Marcelo Sandoval-Denis; Deanna A Sutton; José F Cano-Lira; Josepa Gené; Annette W Fothergill; Nathan P Wiederhold; Josep Guarro
Journal:  J Clin Microbiol       Date:  2014-04-09       Impact factor: 5.948

Review 6.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

7.  Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.

Authors:  Charline Miossec; Florent Morio; Thierry Lepoivre; Patrice Le Pape; Dea Garcia-Hermoso; Françoise Gay-Andrieu; Alain Haloun; Michele Treilhaud; François Leclair; Michel Miegeville
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

Review 8.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

9.  In vitro interactions between antifungals and methotrexate against Aspergillus spp.

Authors:  Jianxun Yang; Zhe Wan; Xiaohong Wang; Wei Liu; Ruoyu Li
Journal:  Mycopathologia       Date:  2009-06-23       Impact factor: 2.574

10.  Combination Antifungal Therapy in the Treatment of Scedosporium apiospermum Central Nervous System Infections.

Authors:  Andrés F Henao-Martínez; José R Castillo-Mancilla; Michelle A Barron; Aran Cunningham Nichol
Journal:  Case Rep Infect Dis       Date:  2013-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.